Financials

News Ideas Forecast

LUP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to LUYE PHARMA GROUP DL-,02 operating, investing, and financing activities

LUP free cash flow for H2 23 is 78.57 M EUR. For 2023, LUP free cash flow was 120.4 M EUR and operating cash flow was 201.49 M EUR.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—